158 related articles for article (PubMed ID: 33717577)
1. The impact of pathologic staging of the hilar/mediastinal nodes on outcomes in patients with early-stage NSCLC receiving stereotactic body radiotherapy.
Mullins BT; Moore DT; Rivera MP; Marks LB; Akulian J; Pearlstein KA; Wang K; Burks AC; Weiner AA
J Thorac Dis; 2021 Feb; 13(2):1045-1054. PubMed ID: 33717577
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
[TBL] [Abstract][Full Text] [Related]
3. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
[TBL] [Abstract][Full Text] [Related]
4. Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLC.
Kennedy WR; Samson PP; Gabani P; Nikitas J; Bradley JD; Roach MC; Robinson CG
Radiother Oncol; 2020 Sep; 150():206-210. PubMed ID: 32622780
[TBL] [Abstract][Full Text] [Related]
5. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
[TBL] [Abstract][Full Text] [Related]
6. The role of endobronchial ultrasound-guided transbronchial needle aspiration in stereotactic body radiation therapy for non-small cell lung cancer.
Hashimoto K; Daddi N; Giuliani M; Hope A; Le LW; Czarnecka K; Cypel M; Pierre A; de Perrot M; Darling G; Waddell TK; Keshavjee S; Yasufuku K
Lung Cancer; 2018 Sep; 123():1-6. PubMed ID: 30089578
[TBL] [Abstract][Full Text] [Related]
7. Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Aghdam N; Lischalk JW; Marin MP; Hall C; O'Connor T; Campbell L; Suy S; Collins SP; Margolis M; Krochmal R; Anderson E; Collins BT
Front Oncol; 2021; 11():728519. PubMed ID: 34912703
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience.
Hobbs CJ; Ko SJ; Paryani NN; Accurso JM; Olivier KR; Garces YI; Park SS; Hallemeier CL; Schild SE; Vora SA; Ashman JB; Rule WG; Bowers JR; Heckman MG; Diehl NN; Miller RC
Mayo Clin Proc Innov Qual Outcomes; 2018 Mar; 2(1):40-48. PubMed ID: 30225431
[TBL] [Abstract][Full Text] [Related]
9. Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer - Results from a Single Institution Study.
George B; Baydoun A; Bhat S; Bailey L; Arsenault T; Sun Y; Zhang Y; Zheng Y; Vempati P; Podder T; Biswas T
Clin Lung Cancer; 2024 Jun; 25(4):e181-e188. PubMed ID: 38553326
[TBL] [Abstract][Full Text] [Related]
10. Added value of invasive needle techniques in mediastinal and hilar nodal staging of clinical N0-N1 non-small cell lung cancer after positron emission tomography.
Collin-Castonguay MM; Guinde J; Laflamme L; Marcoux S; Fortin M
Clin Transl Radiat Oncol; 2020 Sep; 24():49-51. PubMed ID: 32613092
[TBL] [Abstract][Full Text] [Related]
11. Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study.
Steinfort DP; Siva S; Leong TL; Rose M; Herath D; Antippa P; Ball DL; Irving LB
Medicine (Baltimore); 2016 Feb; 95(8):e2488. PubMed ID: 26937894
[TBL] [Abstract][Full Text] [Related]
12. Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
Verma V; Schonewolf CA; Cushman TR; Post CM; Doms A; Berman AT; DeVries M; Katz SI; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):502-510. PubMed ID: 30111509
[TBL] [Abstract][Full Text] [Related]
13. Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score-matched NCDB Analysis.
Cantrell JN; Acharya P; Vesely SK; Gunter TC
Am J Clin Oncol; 2023 Nov; 46(11):503-511. PubMed ID: 37679872
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers.
Horne ZD; Richman AH; Dohopolski MJ; Clump DA; Burton SA; Heron DE
Lung Cancer; 2018 Jan; 115():1-4. PubMed ID: 29290248
[TBL] [Abstract][Full Text] [Related]
15. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients.
Vial MR; Khan KA; O'Connell O; Peng SA; Gomez DR; Chang JY; Rice DC; Mehran R; Jimenez CJ; Grosu HB; Ost DE; Eapen GA
Ann Thorac Surg; 2017 May; 103(5):1600-1605. PubMed ID: 28027732
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of Mediastinal Lymph Node Staging Techniques in the Preoperative Assessment of Nonsmall Cell Lung Cancer Patients.
Fréchet B; Kazakov J; Thiffault V; Ferraro P; Liberman M
J Bronchology Interv Pulmonol; 2018 Jan; 25(1):17-24. PubMed ID: 29261576
[TBL] [Abstract][Full Text] [Related]
17. Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal nodal staging of lung cancer.
Ohnishi R; Yasuda I; Kato T; Tanaka T; Kaneko Y; Suzuki T; Yasuda S; Sano K; Doi S; Nakashima M; Hara T; Tsurumi H; Murakami N; Moriwaki H
Endoscopy; 2011 Dec; 43(12):1082-9. PubMed ID: 21971924
[TBL] [Abstract][Full Text] [Related]
18. Is Biopsy of Contralateral Hilar N3 Lymph Nodes With Negative PET-CT Scan Findings Necessary When Performing Endobronchial Ultrasound Staging?
Sainz Zúñiga PV; Martinez-Zayas G; Molina S; Grosu HB; Arain MH; Ost DE
Chest; 2021 Apr; 159(4):1642-1651. PubMed ID: 33393471
[TBL] [Abstract][Full Text] [Related]
19. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
[TBL] [Abstract][Full Text] [Related]
20. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
